Summary
In this short article for an Australian nursing magazine, New Zealand mental health nurse Jason Watson challenges the idea that withholding gender-affirming treatment from young people drives them to suicide. He looks at six large, long-term studies from the Netherlands, Sweden, Denmark, the UK and Finland. In his reading, suicide rates among transgender people stayed well above the general population after treatment, rates fell over time only for trans women in one Dutch study, and the Tavistock clinic review found no rise in youth suicides after access to puberty blockers was restricted in England. He concludes that the 'transition or suicide' claim is weak at best. The article was printed in July 2026, then removed from the journal's website after complaints; the nurses' union apologised for publishing it but later said this did not imply misconduct by the author. It is an opinion piece, not a systematic review: it picks a handful of studies, most of them about adults, and some of its readings go further than the studies' own authors. For example, the Finnish study it relies on most concluded that suicide risk was explained by mental illness and that gender reassignment did not change suicide risk either way.
Key findings
- Watson questiona a afirmação amplamente repetida de que jovens sem acesso a tratamento de afirmação de gênero correm maior risco de suicídio, afirmação feita pela WPATH e por autoridades de saúde dos EUA.
- Ele analisa seis estudos de acompanhamento de longo prazo dos Países Baixos, da Suécia, da Dinamarca, do Reino Unido e da Finlândia, com entre 324 e mais de 15.000 pessoas e entre 5 e 46 anos de acompanhamento.
- Ele relata que as taxas de suicídio e de morte entre pessoas transgênero continuaram mais altas do que na população geral após o tratamento, e que apenas um estudo holandês encontrou queda do suicídio ao longo do tempo, entre mulheres trans.
- Ele destaca a revisão dos suicídios na clínica Tavistock, na Inglaterra, que identificou 12 suicídios e nenhum aumento de suicídios entre jovens depois da restrição dos bloqueadores da puberdade, apesar das previsões de um aumento acentuado.
- Ele conclui que a narrativa de "transição ou suicídio" é "no mínimo frágil e, no máximo, simplesmente incorreta", em linha com a conclusão da Cass Review de que a maior parte da pesquisa nesta área é de baixa qualidade.
- O sindicato dos enfermeiros da Austrália removeu o artigo do site da revista em julho de 2026 e pediu desculpas por tê-lo publicado, esclarecendo depois que isso não significava uma constatação de má conduta por parte do autor.
Abstract
This short article examines the narrative that trans youth who are not provided with gender-affirming healthcare face an increased risk of suicide, a view stated by WPATH's Standards of Care 8 and the US Assistant Secretary for Health in 2022. Noting the Cass Review's finding that research in this field is of poor quality, the author summarises six long-term follow-up studies from the Netherlands (Wiepjes 2020; de Blok 2021), Sweden (Dhejne 2011), Denmark (Erlangsen 2023), England (Appleby 2024, a review of suicides among Tavistock gender clinic patients) and Finland (Ruuska 2024), with sample sizes from 324 to 15,032 and follow-up from five to 46 years, and describes what each reported about suicide and mortality.
Conclusion
Only one finding, the decline in suicide among trans women over time in Wiepjes (2020), appeared to support the narrative that lack of access to gender-affirming care increases suicide risk. The author argues the other studies showed no evidence that treatment reduced suicidal behaviour, and reported higher 'other' mortality after treatment, and that Ruuska (2024), the only study with a matched control group, found much higher suicide and overall mortality among trans people. He concludes the 'trans suicide narrative' is 'at least tenuous and at most simply incorrect', consistent with the Cass Review's view that most research in this field is of poor quality.